102 related articles for article (PubMed ID: 2887045)
21. Characterization of DR blank alleles by restriction fragment length polymorphism (RFLP).
Keller E; Andreas-Zietz A; McNicholas A; Grooms A; Scholz S; Albert ED
Tissue Antigens; 1987 Mar; 29(3):154-9. PubMed ID: 2885945
[TBL] [Abstract][Full Text] [Related]
22. HLA-DQ heterogeneity among HLA-DRw11(5) haplotypes.
Amar A; Mickelson E; Hansen JA; Nepom GT
Tissue Antigens; 1986 Nov; 28(5):278-87. PubMed ID: 2881380
[TBL] [Abstract][Full Text] [Related]
23. Analysis of HLA-DRB and -DQB gene RFLPs in DR7 homozygous cell lines: associations with Dw11, Dw17 and DB1.
Carlsson B; Wallin J
Tissue Antigens; 1991 Feb; 37(2):74-8. PubMed ID: 1676192
[TBL] [Abstract][Full Text] [Related]
24. A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10.
Bidwell JL; Bidwell EA; Savage DA; Middleton D; Klouda PT; Bradley BA
Transplantation; 1988 Mar; 45(3):640-6. PubMed ID: 2894727
[TBL] [Abstract][Full Text] [Related]
25. Analysis of DR beta and DQ beta chain cDNA clones from a DR7 haplotype.
Karr RW; Gregersen PK; Obata F; Goldberg D; Maccari J; Alber C; Silver J
J Immunol; 1986 Nov; 137(9):2886-90. PubMed ID: 3020127
[TBL] [Abstract][Full Text] [Related]
26. Induction of various HLA class II molecules in a human colonic adenocarcinoma cell line.
Sollid LM; Gaudernack G; Markussen G; Kvale D; Brandtzaeg P; Thorsby E
Scand J Immunol; 1987 Feb; 25(2):175-80. PubMed ID: 2434988
[TBL] [Abstract][Full Text] [Related]
27. [Class II HLA antigens and rheumatoid factors in rheumatoid polyarthritis. Inverse influence of DR4 and DR7 antigens?].
Cohen JH; Blanchard F; Vischer TL
Rev Rhum Mal Osteoartic; 1986 Nov; 53(11):639-41. PubMed ID: 3497427
[TBL] [Abstract][Full Text] [Related]
28. HLA-DR and DQ matching by DNA restriction fragment length polymorphism methods and the outcome of mixed lymphocyte reaction tests in unrelated bone marrow donor searches. The IMUST Study.
Howard MR; Brookes P; Bidwell JL; Bidwell EA; Clay TM; Evans JL; Hows JM; Bradley BA
Bone Marrow Transplant; 1992 Mar; 9(3):161-6. PubMed ID: 1354994
[TBL] [Abstract][Full Text] [Related]
29. HLA class II typing by digestion of PCR-amplified DNA with allele-specific restriction endonucleases will fail to unequivocally identify the genotypes of many homozygous and heterozygous individuals.
Olerup O
Tissue Antigens; 1990 Aug; 36(2):83-7. PubMed ID: 1980163
[TBL] [Abstract][Full Text] [Related]
30. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
Matsuyama T; Schwenzer J; Silver J; Winchester R
J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991
[TBL] [Abstract][Full Text] [Related]
31. HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers.
Ota M; Seki T; Fukushima H; Tsuji K; Inoko H
Tissue Antigens; 1992 Apr; 39(4):187-202. PubMed ID: 1356282
[TBL] [Abstract][Full Text] [Related]
32. HLA class II DR, DQ, and DP restriction fragment length polymorphisms in rheumatoid arthritis.
Howell WM; Evans PR; Wilson PJ; Cawley MI; Smith JL
Ann Rheum Dis; 1989 Apr; 48(4):295-301. PubMed ID: 2565707
[TBL] [Abstract][Full Text] [Related]
33. HLA-DR restriction-fragment-length polymorphisms in narcolepsy.
Holloman JD; Bell JI; Kilduff TS; Dement WC; Guilleminault C; McDevitt HO
J Neurosci Res; 1987; 18(1):239-44. PubMed ID: 2890770
[TBL] [Abstract][Full Text] [Related]
34. Restriction fragment length polymorphism of HLA and non-HLA genes in DR3/4 heterozygous Danish insulin-dependent diabetic patients and healthy individuals: reassessment of the influence of alpha DX and insulin-linked polymorphic loci, and new splits of DQw3 haplotypes.
Zerbib A; Mølvig J; Thomsen M; Coppin H; Cambon-Thomsen A; Sommer E; Nerup J; De Preval C
Dis Markers; 1989; 7(1):27-41. PubMed ID: 2565778
[TBL] [Abstract][Full Text] [Related]
35. HLA-DR RFLP distributions in two groups of aboriginal Australians.
Davies R; Pace R; Jazwinska EC; Serjeantson SW
Aust N Z J Med; 1990 Dec; 20(6):790-3. PubMed ID: 1981309
[TBL] [Abstract][Full Text] [Related]
36. Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients.
Ottenhoff TH; Neuteboom S; Elferink DG; de Vries RR
J Exp Med; 1986 Dec; 164(6):1923-39. PubMed ID: 2431092
[TBL] [Abstract][Full Text] [Related]
37. A possible linkage of HLA-DRB haplotypes with Tiopronin intolerance in rheumatoid arthritis.
Ju LY; Paolozzi L; Delecoeuillerie G; Bourgeois P; Khodja M; Legoff P; Liote F; Sheffer V; Amor B; Charron D
Clin Exp Rheumatol; 1994; 12(3):249-54. PubMed ID: 7915222
[TBL] [Abstract][Full Text] [Related]
38. Restriction fragment length polymorphism analysis of HLA haplotypes in families with type I diabetes mellitus.
Badenhoop K; Schwarz G; Bingley P; Lewis V; Drummond V; Gale EA; Bottazzo GF
Tissue Antigens; 1990 Jan; 35(1):32-9. PubMed ID: 1968292
[TBL] [Abstract][Full Text] [Related]
39. HLA-DR typing using restriction fragment length polymorphism (RFLP) with one enzyme and two probes.
Riisom K; Søorensen IJ; Møoller B; Kruse TA; Graugaard B; Lamm LU
Tissue Antigens; 1988 Mar; 31(3):141-50. PubMed ID: 2897728
[TBL] [Abstract][Full Text] [Related]
40. HLA class II antigens and DNA restriction fragment length polymorphism in myasthenia gravis in Japan.
Morita K; Moriuchi J; Inoko H; Tsuji K; Arimori S
Ann Neurol; 1991 Feb; 29(2):168-74. PubMed ID: 1672809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
